UTL-5g

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameUTL-5g
Drug Alias NameUTL-5g
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsRadiation InjuriesSepsis +[3] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator Companies21st Century Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSichuan Newphiaring Bio-medical Science Co Ltd21st Century Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsRadiation InjuriesSepsis +[3] 

Other Information

ATC CodeN/A
Related LinksN/A